CWM
NVO

Cedar Wealth Management’s Novo Nordisk NVO Stock Holding History

Cedar Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-98
Closed -$12.6K – 336
2024
Q1 		$12.6K Buy
+98
New +$11.7K ﹤0.01% 245
2020
Q4 		– Sell
-228
Closed -$8K – 238
2020
Q3 		$8K Hold
228
– – 0.01% 193
2020
Q2 		$7K Hold
228
– – ﹤0.01% 195
2020
Q1 		$7K Buy
+228
New +$6.79K ﹤0.01% 200

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Cedar Wealth Management's NVO Position: Q2 2024 in Review

Cedar Wealth Management sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 98 shares — an estimated $12.6K sold.

Cedar Wealth Management first reported a position in NVO in Q1 2020 and held it in 4 quarters. The position peaked at $12.6K in Q1 2024. 1,860 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Cedar Wealth Management reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Cedar Wealth Management sold 98 Novo Nordisk shares in Q2 2024, an estimated $12.6K.
  • Cedar Wealth Management first reported a position in Novo Nordisk in Q1 2020 and held it in 4 quarters.
  • Cedar Wealth Management's Novo Nordisk position peaked at $12.6K in Q1 2024.
  • 1,860 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Cedar Wealth Management's 13F filing for Q2 2024, filed 12 Aug 2024.